This was an open-label, multicenter, randomized, controlled clinical trial. At 4 medical centers, a total of 111 severe/critical patients were randomly assigned to receive Shenhuang Granule (SHG group) twice a day for 14 days, in addition to standard care, or to receive standard care alone (Control group). The maximal follow …
Read More »
Acupuncture Times Your guide to acupuncture, Chinese herbal medicine and TCM — explore acupoints, herbs and formulas, plus the latest acupuncture research news.